Newborn hearing screening definition

Newborn hearing screening means a physiological test to separate those newborns with normal hearing from those newborns who may have hearing thresholds of greater than 30 dB HL in either ear in the frequency region important for speech recognition (500-4000 Hz).
Sample 1Sample 2Sample 3
Newborn hearing screening means the completion of an objective, physiological test or battery of tests administered to determine the infant's hearing status and the need for further diagnostic testing by an audiologist with expertise in infant and pediatric audiology or physician with the Department approved instrumentation, protocols and pass/refer criteria.
Sample 1Sample 2
Newborn hearing screening means a physiological test to separate those newborns with normal hearing from those newborns who may have hearing thresholds of greater than 30 dB HL in either ear
Sample 1

Examples of Newborn hearing screening in a sentence

  • Newborn hearing screening program” means a system of a hospital under which an infant may be tested, using currently available medical techniques, to determine if the infant has a hear- ing loss.

  • Screeners should complete a hearing screening training curriculum directed by an audiologist licensed in Georgia with initial and annual competency documented (4) Where to Screen Newborn hearing screening may be performed in the nursery, mother’s hospital room, designated quiet room, or NICU.

  • Newborn hearing screening, audiological assessment and follow-up, f.

  • It is advisable to screen after an infant has completed nursing or feeding, to increase the chance of the infant sleeping during the screeningo Newborn hearing screening is more efficient and accurate when the newborn is quiet and contento Swaddling a baby is often helpful4.

  • Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission.

  • Newborn hearing screening and assessment: Guidance for auditory brainstem response testing in babies, v2.1. NHS Antenatal Newborn Hearing Screening Programmes.

  • Newborn hearing screening (NHS) and follow- up services are included in Healthy People 2020—the nation’s current comprehensive health promotion and disease prevention agenda.

  • Newborn hearing screening in a South African private health care hospital.

  • Newborn hearing screening should be performed on all newborns prior to one (1) month of age, using portable equipment if needed.

  • Newborn hearing screening vs later hearing screening and developmental outcomes in children with permanent childhood hearing impairment.


More Definitions of Newborn hearing screening

Newborn hearing screening means the completion of an objective, physiological test or battery of tests administered to determine the infant's hearing status and the need
Sample 1

Related to Newborn hearing screening

  • Plan hearing means the public hearing on the draft Project Area Plan required under Subsection 17C-1-102 (41) and 17C-5-104(3)(e).

  • Permanency hearing means a hearing, conducted with respect to a child who is in foster care, to determine the permanency plan for the child which includes:

  • Confirmation Hearing means the hearing held by the Bankruptcy Court pursuant to section 1128 of the Bankruptcy Code to consider confirmation of this Plan, as such hearing may be adjourned or continued from time to time.

  • Fair Hearing means the State hearing provided to beneficiaries upon denial of appeal pursuant to 22 CCR 50951 and 50953 and 9 CCR 1810.216.6. Fair hearings must comply with 42 CFR 431.220(a)(5), 438.408(f), 438.414, and 438.10(g)(1).

  • Newborn means a baby less than nine days old.

  • Hearing aid means an instrument or device designed for regular and constant use in or proximate to the human ear and represented as aiding or improving defective human hearing.

  • Phase III Trial means a human Clinical Trial of the Licensed Product, which trial is designed (a) to establish that the Licensed Product is safe and efficacious for its intended use; (b) to define warnings, precautions and adverse reactions that are associated with the Licensed Product in the dosage range to be prescribed; and (c) consistent with 21 CFR § 312.21(c).

  • ODJFS means the Ohio Department of Job and Family Services.

  • Court Hearing means the hearing by the High Court of the Petition to sanction the Scheme under Section 453 of the Act.

  • Disenrollment means either voluntary or involuntary termination of a participant from the Independent Choices Program.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • HMO means health maintenance organization.

  • Pivotal Trial means a clinical study in humans of the efficacy and safety of a Licensed Product that is prospectively designed to demonstrate with statistical significance that such product is effective and safe for use in a particular indication in a manner sufficient to file for Marketing Approval of such product and would satisfy the requirements of 21 CFR 312.21(c), or a similar clinical study prescribed by the Regulatory Authorities in a country other than the United States.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • Enrollee means any person entitled to health care services from a carrier.

  • Prosthesis means an artificial substitute for a missing body part.

  • Hearing means an oral hearing and includes a hearing conducted in whole or in part by video link, telephone or other means of instantaneous two-way electronic communication;

  • Participating Clinical Social Worker means a Clinical Social Worker who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Participating Prescription Drug Provider means an independent retail Pharmacy, chain of retail Pharmacies, mail-order Pharmacy or specialty drug Pharmacy which has entered into an agreement to provide pharmaceutical services to participants in the benefit program. A retail Participating Pharmacy may or may not be a select Participating Pharmacy as that term is used in the Vaccinations Obtained Through Participating Pharmacies section.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Sale Hearing means the hearing conducted by the Bankruptcy Court to approve the transactions contemplated by this Agreement.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.